R A Bok

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study
    R A Bok
    University of California at San Francisco, Comprehensive Cancer Center, 94143 0324, USA
    Cancer Res 61:2533-6. 2001
  2. ncbi Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model
    R A Bok
    Department of Medicine, University of California, San Francisco, California 94143, USA
    Prostate Cancer Prostatic Dis 6:272-80. 2003

Detail Information

Publications2

  1. ncbi Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study
    R A Bok
    University of California at San Francisco, Comprehensive Cancer Center, 94143 0324, USA
    Cancer Res 61:2533-6. 2001
    ..These results support the notion that certain peptide growth factor-mediated, mitogenic pathways are important in HRPC and that their levels can predict outcome...
  2. ncbi Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model
    R A Bok
    Department of Medicine, University of California, San Francisco, California 94143, USA
    Prostate Cancer Prostatic Dis 6:272-80. 2003
    ..Our results implicate pericellular proteases as initiators of major proteolytic cascades during tumor progression and suggest targets for maximal therapeutic effect...